Enveric Biosciences Inc (NASDAQ:ENVB) currently has a daily average trading volume of 1.35M but it saw 1795214 shares traded in last market. With a market cap of 4.30M USD, the company’s current market price of $0.48 came rising about 14.04 while comparing to the previous closing price of $0.42. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.92 and as low as $0.36. In the recent trading on the day, stock has struck highest price mark of $0.3834 while lowest mark touched by it was $0.485.
Taking a look at 20-day trading activity of Enveric Biosciences Inc (ENVB) gives us an average price of $0.4494, while its current price level is -83.48% below from 52-week high level whereas it is 33.70% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4903 while that of 200 days or SMA-200 reads an average of $0.7795. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.61% during that period while stretching the period over a month that decreases to 8.46%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 55.71 which implies that the stock is in neutral territory.
Over the week, ENVB’s stock price is moving 15.21% up while it is -4.32% when we observe its performance for the past one month. Year-to-date it is -62.89% down and over the past year, the stock is showing a downside performance of -76.70%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -1.3 beat the consensus estimate of -2.09 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of -0.52 while estimate for next year EPS is -2.08.
Currently, Enveric Biosciences Inc’s total number of outstanding shares is 8.92M. Company’s return on investment (ROI) stands at -195.97% and return on equity (ROE) at -206.10%. Stock’s beta reads 0.73. Stock has a price to book (P/B) ratio of 0.70. Its return on asset (ROA) is -133.67% on average.
